1-19 of 19
Tomasz M. Beer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A056: Performance of multi-biomarker class reflex testing in a prospectively-collected cohort

Vladimir Gainullin, Jin Bae, Violeta Beleva Guthrie, Fanglei Zhuang, Chen Ji, Christopher Tyson, Mark Evans, Kevin Arvai, Melissa Gray, Madhav Kumar, Mael Manesse, Xi Chen, Philip Uren, Gustavo C. Cerqueira, Amin Mazloom, Jorge Garces, Tomasz M. Beer, Frank Diehl
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): A056.
https://doi.org/10.1158/1557-3265.LIQBIOP24-A056
Published: 13 November 2024
View article titled, Abstract A056: Performance of multi-biomarker class reflex testing in a prospectively-collected cohort
Journal Articles

Abstract A064: Lung cancer screening adherence among participants in DETECT-A, the first prospective interventional trial of a multi-cancer early detection (MCED) blood test

Adam H. Buchanan, Anne Marie Lennon, Paul Z. Elias, Amy M. Lehman, Yongqiang Zhang, Darl D. Flake, II, Eric S. Wagner, Seema P. Rego, Omair A. Choudhry, Nickolas Papadopoulos, Tomasz M. Beer
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): A064.
https://doi.org/10.1158/1557-3265.LIQBIOP24-A064
Published: 13 November 2024
View article titled, Abstract A064: Lung cancer screening adherence among participants in DETECT-A, the first prospective interventional trial of a multi-cancer early detection (MCED) blood test
Journal Articles

Abstract A073: The potential of multi-cancer early detection screening for reducing cancer mortality

Jagpreet Chhatwal, Jade Xiao, Andrew ElHabr, Christopher Tyson, Xiting Cao, Sana Raoof, A. Mark Fendrick, A. Burak Ozbay, Paul Limburg, Tomasz M. Beer, Ashish Deshmukh, Andrew Briggs
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): A073.
https://doi.org/10.1158/1557-3265.LIQBIOP24-A073
Published: 13 November 2024
View article titled, Abstract A073: The potential of multi-cancer early detection screening for reducing cancer mortality
Journal Articles

Abstract PR006: The potential of multi-cancer early detection screening for reducing cancer mortality

Jagpreet Chhatwal, Jade Xiao, Andrew ElHabr, Christopher Tyson, Xiting Cao, Sana Raoof, A. Mark Fendrick, A. Burak Ozbay, Paul Limburg, Tomasz M. Beer, Ashish Deshmukh, Andrew Briggs
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): PR006.
https://doi.org/10.1158/1557-3265.LIQBIOP24-PR006
Published: 13 November 2024
View article titled, Abstract PR006: The potential of multi-cancer early detection screening for reducing cancer mortality
Journal Articles

Autoantibody Landscape in Patients with Advanced Prostate Cancer

William S. Chen, Winston A. Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha, Minlu Zhang, Adam Foye, Ignacio Baselga Carretero, Ivan Perez Garcilazo, Meng Zhang, Shuang G. Zhao, Martin Sjöström, David A. Quigley, Jonathan Chou, Tomasz M. Beer, Matthew Rettig, Martin Gleave, Christopher P. Evans, Primo Lara, Kim N. Chi, Robert E. Reiter, Joshi J. Alumkal, Alan Ashworth, Rahul Aggarwal, Eric J. Small, Patrick S. Daugherty, Antoni Ribas, David Y. Oh, John C. Shon, Felix Y. Feng
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6204–6214.
https://doi.org/10.1158/1078-0432.CCR-20-1966
Published: 01 December 2020
View article titled, Autoantibody Landscape in Patients with Advanced Prostate Cancer
Open the PDF for Autoantibody Landscape in Patients with Advanced Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

Xiangnan Guan, Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert Evan Reiter, Matthew Rettig, Christopher P. Evans, Primo Lara, Jr, Martin Gleave, Tomasz M. Beer, George V. Thomas, Jiaoti Huang, Rahul R. Aggarwal, David A. Quigley, Adam Foye, William S. Chen, Jack Youngren, Alana S. Weinstein, Joshua M. Stuart, Felix Y. Feng, Eric J. Small, Zheng Xia, Joshi J. Alumkal
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4616–4624.
https://doi.org/10.1158/1078-0432.CCR-19-2303
Published: 01 September 2020
View article titled, Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

Anna C. Ferrari, Joshi J. Alumkal, Mark N. Stein, Mary-Ellen Taplin, James Babb, Ethan S. Barnett, Alejandro Gomez-Pinillos, Xiaomei Liu, Dirk Moore, Robert DiPaola, Tomasz M. Beer
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2672.
https://doi.org/10.1158/1078-0432.CCR-19-0442
Published: 15 April 2019
View article titled, Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer
Open the PDF for Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer in another window
Journal Articles

Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer

Anna C. Ferrari, Joshi J. Alumkal, Mark N. Stein, Mary-Ellen Taplin, James Babb, Ethan S. Barnett, Alejandro Gomez-Pinillos, Xiaomei Liu, Dirk Moore, Robert DiPaola, Tomasz M. Beer
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 52–63.
https://doi.org/10.1158/1078-0432.CCR-18-1589
Published: 03 January 2019
View article titled, Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer
Open the PDF for Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A12: Identification of pathways associated with abiraterone resistance in metastatic castration resistant prostate cancer: Preliminary results from the SU2C/AACR West Coast Prostate Cancer Dream Team

Jack F. Youngren, Adam Foye, George Thomas, Joshua M. Stuart, Ted Goldstein, Baertsch Robert, Adrian Bivol, Artem Sokolov, Charles J. Ryan, Nader Pourmand, Tomasz M. Beer, Christopher P. Evans, Christopher P. Evans, Primo Lara, Jr., Martin E. Gleave, Kim N. Chi, Robert E. Reiter, Matthew Rettig, Owen Witte, Eric J. Small
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): A12.
https://doi.org/10.1158/1557-3265.PMS14-A12
Published: 13 February 2015
View article titled, Abstract A12: Identification of pathways associated with abiraterone resistance in metastatic castration resistant prostate cancer: Preliminary results from the SU2C/AACR West Coast Prostate Cancer Dream Team
Journal Articles

Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer

Christine M. Barnett, Michael C. Heinrich, Jeong Lim, Dylan Nelson, Carol Beadling, Andrea Warrick, Tanaya Neff, Celestia S. Higano, Mark Garzotto, David Qian, Christopher L. Corless, George V. Thomas, Tomasz M. Beer
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (5): 1306–1312.
https://doi.org/10.1158/1078-0432.CCR-13-1775
Published: 02 March 2014
View article titled, Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer
Open the PDF for Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer

Tomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glode, Simon J. Hall, Wayne L. Poll, Paul F. Schellhammer, Lori A. Jones, Yi Xu, Jelle W. Kylstra, Mark W. Frohlich
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4558–4567.
https://doi.org/10.1158/1078-0432.CCR-10-3223
Published: 05 July 2011
View article titled, Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
Open the PDF for Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer in another window
Journal Articles

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Mary-Ellen Taplin, Meredith M. Regan, Yoo-Joung Ko, Glenn J. Bubley, Stephen E. Duggan, Lillian Werner, Tomasz M. Beer, Christopher W. Ryan, Paul Mathew, Shi-Ming Tu, Samuel R. Denmeade, William K. Oh, Oliver Sartor, Christos S. Mantzoros, Roger Rittmaster, Philip W. Kantoff, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7099–7105.
https://doi.org/10.1158/1078-0432.CCR-09-1722
Published: 11 November 2009
View article titled, Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Open the PDF for Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer in another window
Journal Articles

Prostate Cancer–Associated Gene Expression Alterations Determined from Needle Biopsies

David Z. Qian, Chung-Ying Huang, Catherine A. O'Brien, Ilsa M. Coleman, Mark Garzotto, Lawrence D. True, Celestia S. Higano, Robert Vessella, Paul H. Lange, Peter S. Nelson, Tomasz M. Beer
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3135–3142.
https://doi.org/10.1158/1078-0432.CCR-08-1982
Published: 30 April 2009
View article titled, Prostate Cancer–Associated Gene Expression Alterations Determined from Needle Biopsies
Open the PDF for Prostate Cancer–Associated Gene Expression Alterations Determined from Needle Biopsies in another window
Includes: Supplementary data
Journal Articles

The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells

Anne Myrthue, Brooks L.S. Rademacher, Janet Pittsenbarger, Bozena Kutyba-Brooks, Marin Gantner, David Z. Qian, Tomasz M. Beer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3562–3570.
https://doi.org/10.1158/1078-0432.CCR-07-4649
Published: 02 June 2008
View article titled, The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D<sub>3</sub> in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells
Open the PDF for The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D<sub>3</sub> in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells in another window
Journal Articles

Molecular Alterations in Prostate Carcinomas that Associate with In vivo Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15

Chung-Ying Huang, Tomasz M. Beer, Celestia S. Higano, Lawrence D. True, Robert Vessella, Paul H. Lange, Mark Garzotto, Peter S. Nelson
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5825–5833.
https://doi.org/10.1158/1078-0432.CCR-07-1037
Published: 01 October 2007
View article titled, Molecular Alterations in Prostate Carcinomas that Associate with <em>In vivo</em> Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15
Open the PDF for Molecular Alterations in Prostate Carcinomas that Associate with <em>In vivo</em> Exposure to Chemotherapy: Identification of a Cytoprotective Mechanism Involving Growth Differentiation Factor 15 in another window
Includes: Supplementary data
Journal Articles

Effect of Calcitriol on Prostate-Specific Antigen In vitro and in Humans

Tomasz M. Beer, Mark Garzotto, Byung Park, Motomi Mori, Anne Myrthue, Nicole Janeba, David Sauer, Kristine Eilers
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2812–2816.
https://doi.org/10.1158/1078-0432.CCR-05-2310
Published: 04 May 2006
View article titled, Effect of Calcitriol on Prostate-Specific Antigen <em>In vitro</em> and in Humans
Open the PDF for Effect of Calcitriol on Prostate-Specific Antigen <em>In vitro</em> and in Humans in another window
Journal Articles

Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer

Tomasz M. Beer, Milind Javle, Gilbert N. Lam, W. David Henner, Alvin Wong, Donald L. Trump
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7794–7799.
https://doi.org/10.1158/1078-0432.CCR-05-0552
Published: 08 November 2005
View article titled, Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer
Open the PDF for Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer in another window
Journal Articles

In vivo Bioavailability and Pharmacokinetics of a c-MYC Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors

Gayathri R. Devi, Tomasz M. Beer, Christopher L. Corless, Vikram Arora, Doreen L. Weller, Patrick L. Iversen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3930–3938.
https://doi.org/10.1158/1078-0432.CCR-04-2091
Published: 16 May 2005
View article titled, <em>In vivo</em> Bioavailability and Pharmacokinetics of a <em>c-MYC</em> Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors
Open the PDF for <em>In vivo</em> Bioavailability and Pharmacokinetics of a <em>c-MYC</em> Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors in another window
Journal Articles

Phase I Study of Weekly Mitoxantrone and Docetaxel before Prostatectomy in Patients with High-Risk Localized Prostate Cancer

Tomasz M. Beer, Mark Garzotto, Bruce A. Lowe, William J. Ellis, Michelle A. Montalto, Paul H. Lange, Celestia S. Higano
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1306–1311.
https://doi.org/10.1158/1078-0432.CCR-1021-03
Published: 20 February 2004
View article titled, Phase I Study of Weekly Mitoxantrone and Docetaxel before Prostatectomy in Patients with High-Risk Localized Prostate Cancer
Open the PDF for Phase I Study of Weekly Mitoxantrone and Docetaxel before Prostatectomy in Patients with High-Risk Localized Prostate Cancer in another window